☆ 4.6 Article

Enteral supplementation with high-dose docosahexaenoic acid on the risk of bronchopulmonary dysplasia in very preterm infants: a collaborative study protocol for an individual participant data meta-analysis

BMJ OPEN (2023)

Related references

Note: Only part of the references are listed.

Review Medicine, General & Internal

Association Between Enteral Supplementation With High-Dose Docosahexaenoic Acid and Risk of Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review and Meta-analysis

Isabelle Marc et al.

Summary: This systematic review and meta-analysis examines the association between daily omega-3 docosahexaenoic acid (DHA) supplementation and bronchopulmonary dysplasia (BPD) in preterm infants born at less than 29 weeks' gestation. The study found that high-dose DHA supplementation during the neonatal period was not associated with BPD overall, but was inversely associated with BPD in trials that used a more stringent definition. These findings suggest that high-dose DHA supplementation should not be recommended for the prevention of BPD in very preterm infants.

JAMA NETWORK OPEN (2023)

Add to Collection

Article Pediatrics

Maternal High-Dose DHA Supplementation and Neurodevelopment at 18-22 Months of Preterm Children

Mireille Guillot et al.

Summary: This study aimed to determine whether maternal supplementation with high-dose docosahexaenoic acid (DHA) improved neurodevelopmental outcomes in breastfed, very preterm neonates at 18 to 22 months' corrected age. The study found that overall, maternal DHA supplementation did not improve neurodevelopmental outcomes at 18 to 22 months' corrected age in breastfed, preterm neonates. However, subgroup analyses suggested a potential benefit for language in preterm neonates born before 27 weeks' gestational age.

PEDIATRICS (2022)

Add to Collection

Article Medicine, General & Internal

Neonatal Docosahexaenoic Acid in Preterm Infants and Intelligence at 5 Years

Jacqueline F. Gould et al.

Summary: Limited research suggests that DHA supplementation in infants born before 29 weeks of gestation may have a positive impact on cognitive development.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Review Medicine, General & Internal

High doses of enteral docosahexaenoic acid omega-3 supplementation for prevention of bronchopulmonary dysplasia in very preterm infants: a protocol for a systematic review and meta-analysis

Isabelle Marc et al.

Summary: This study aims to evaluate the effects of high doses of enteral DHA supplementation on bronchopulmonary dysplasia (BPD) in very preterm infants. The study will conduct a systematic review and meta-analysis, searching for relevant randomized controlled trials and analyzing the data. The findings will provide evidence for clinicians and families to make informed decisions.

BMJ OPEN (2022)

Add to Collection

Article Mathematical & Computational Biology

One-stage individual participant data meta-analysis models for continuous and binary outcomes: Comparison of treatment coding options and estimation methods

Richard D. Riley et al.

STATISTICS IN MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Effect of Maternal Docosahexaenoic Acid Supplementation on Bronchopulmonary Dysplasia-Free Survival in Breastfed Preterm Infants A Randomized Clinical Trial

Isabelle Marc et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Critical Care Medicine

The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants An Evidence-based Approach

Erik A. Jensen et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)

Add to Collection

Article Gastroenterology & Hepatology

A Randomized Trial of Maternal Docosahexaenoic Acid Supplementation to Reduce Inflammation in Extremely Preterm Infants

Christina J. Valentine et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2019)

Add to Collection

Article Pediatrics

Bronchopulmonary Dysplasia: Executive Summary of a Workshop

Rosemary D. Higgins et al.

JOURNAL OF PEDIATRICS (2018)

Add to Collection

Article Public, Environmental & Occupational Health

Maelstrom Research guidelines for rigorous retrospective data harmonization

Isabel Fortier et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2017)

Add to Collection

Article Medicine, General & Internal

Docosahexaenoic Acid and Bronchopulmonary Dysplasia in Preterm Infants

Carmel T. Collins et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Add to Collection

Article Health Care Sciences & Services

When and how should multiple imputation be used for handling missing data in randomised clinical trials - a practical guide with flowcharts

Janus Christian Jakobsen et al.

BMC MEDICAL RESEARCH METHODOLOGY (2017)

Add to Collection

Article Pediatrics

Early postnatal docosahexaenoic acid levels and improved preterm brain development

Emily W. Y. Tam et al.

PEDIATRIC RESEARCH (2016)

Add to Collection

Article Pediatrics

A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants

Tanis R. Fenton et al.

BMC PEDIATRICS (2013)

Add to Collection

Review Pediatrics

The new bronchopulmonary dysplasia

Alan H. Jobe

CURRENT OPINION IN PEDIATRICS (2011)

Add to Collection

Article Pediatrics

High-Dose Docosahexaenoic Acid Supplementation of Preterm Infants: Respiratory and Allergy Outcomes

Brett J. Manley et al.

PEDIATRICS (2011)

Add to Collection

Article Medicine, General & Internal

Neurodevelopmental Outcomes of Preterm Infants Fed High-Dose Docosahexaenoic Acid A Randomized Controlled Trial

Maria Makrides et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)

Add to Collection

Article Medicine, General & Internal

Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months - Results from the trial of indomethacin prophylaxis in preterms

B Schmidt et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.